Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection

Journal of Clinical Pharmacy and Therapeutics

Volumn 37, Issue 4, 2012, Pages 431-435

  Nakano, T ^a   Shimizu, K ^a   Kawashima, O ^a   Kamiyoshihara, M ^a   Nagashima, T ^a   Ibe, T ^a   Takeyoshi, I ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

atrial fibrillation; landiolol; pulmonary resection; supraventricular tachycardia

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; FLECAINIDE ACETATE; LANDIOLOL; PILSICAINIDE; VERAPAMIL;

ADULT; AGED; ARTICLE; CIRCULATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DECORTICATION; DISEASE CONTROL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART RATE; HUMAN; LUNG LOBECTOMY; LUNG RESECTION; MALE; MULTICENTER STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RECURRENT DISEASE; RESPIRATORY SYSTEM; RISK REDUCTION; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; SURGICAL PATIENT;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ATRIAL FLUTTER; FEMALE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; LUNG DISEASES; MALE; MIDDLE AGED; MORPHOLINES; RECURRENCE; RETROSPECTIVE STUDIES; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME; UREA;

EID: 84861113400     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2011.01315.x     Document Type: Article

References (20)

1. Amar D, Burt M, Reinsel RA, Leung DH,. Relationship of early postoperative dysrhythmias and long-term outcome after resection of non-small cell lung cancer. Chest, 1996; 110, 437-439. (Pubitemid 26269275)
2. Roselli EE, Murthy SC, Rice TW, et al. Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg, 2005; 130, 438-444. (Pubitemid 41078762)
3. Amar D, Roistacher N, Rusch VW, et al. Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery. J Thorac Cardiovasc Surg, 2000; 120, 790-798.
4. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med, 2002; 347, 1825-1833. (Pubitemid 35417773)
5. Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med, 2008; 358, 2667-2677. (Pubitemid 351860859)
6. Atarashi H, Kuruma A, Yashima M, et al. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther, 2000; 68, 143-150. (Pubitemid 30659169)
7. Iguchi S, Iwamura H, Nishizaki M, et al. Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101. Chem Pharm Bull (Tokyo), 1992; 40, 1462-1469.
8. Ritchie AJ, Danton M, Gibbons JR,. Prophylactic digitalisation in pulmonary surgery. Thorax, 1992; 47, 41-43.
9. Kirsh MM, Rotman H, Behrendt DM, Orringer MB, Sloan H,. Complications of pulmonary resection. Ann Thorac Surg, 1975; 20, 215-236.
10. Barbetakis N, Vassiliadis M,. Is amiodarone a safe antiarrhythmic to use in supraventricular tachyarrhythmias after lung cancer surgery? BMC Surg, 2004; 4, 7.
11. Harpole DH, Liptay MJ, DeCamp MM Jr, Mentzer SJ, Swanson SJ, Sugarbaker DJ,. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg, 1996; 61, 977-982. (Pubitemid 26084563)
12. Wariishi S, Yamashita K, Nishimori H, et al. Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose. Interact Cardiovasc Thorac Surg, 2009; 9, 811-813.
13. Fujiwara H, Sakurai M, Namai A, Kawamura T,. Effect of low-dose landiolol, an ultrashort-acting beta-blocker, on postoperative atrial fibrillation after CABG surgery. Gen Thorac Cardiovasc Surg, 2009; 57, 132-137.
14. Motomura S, Hagihara A, Narumi Y, Hashimoto K,. Time course of a new ultrashort-acting beta-adrenoceptor-blocking drug, ONO-1101: comparison with those of esmolol and propranolol by using the canine isolated, blood-perfused heart preparations. J Cardiovasc Pharmacol, 1998; 31, 431-440. (Pubitemid 28103624)
15. Sugiyama A, Takahara A, Hashimoto K,. Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. J Cardiovasc Pharmacol, 1999; 34, 70-77. (Pubitemid 29296139)
16. Miwa Y, Ikeda T, Mera H, et al. Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs. Circ J, 2010; 74, 856-863.
17. Handschin AE, Lardinois D, Schneiter D, Bloch K, Weder W,. Acute amiodarone-induced pulmonary toxicity following lung resection. Respiration, 2003; 70, 310-312. (Pubitemid 36980779)
18. Kaushik S, Hussain A, Clarke P, Lazar HL,. Acute pulmonary toxicity after low-dose amiodarone therapy. Ann Thorac Surg, 2001; 72, 1760-1761. (Pubitemid 33049811)
19. Van Mieghem W, Coolen L, Malysse I, Lacquet LM, Deneffe GJ, Demedts MG,. Amiodarone and the development of ARDS after lung surgery. Chest, 1994; 105, 1642-1645. (Pubitemid 24180643)
20. Bobbio A, Caporale D, Internullo E, et al. Postoperative outcome of patients undergoing lung resection presenting with new-onset atrial fibrillation managed by amiodarone or diltiazem. Eur J Cardiothorac Surg, 2007; 31, 70-74. (Pubitemid 44880767)